Loading Events

« All Events

5th Viral Vector Process Development & Manufacturing Summit

February 24, 2027 - February 25, 2027

The 5th Annual Viral Vector Process Development & Manufacturing Summit brings together leaders across CMC, process development, manufacturing, MSAT, operations, and regulatory affairs to advance robust, reliable, and reproducible viral vector manufacturing platforms. As the industry shifts towards optimizing proven AAV and LVV platforms, the summit focuses on overcoming the challenges of scalable manufacturing, process consistency, regulatory readiness, and commercial success.

Through real-world case studies, scientific presentations, panel discussions, and networking opportunities, attendees will explore strategies to improve vector yield, enhance empty/full capsid separation, optimize transfection and purification processes, reduce cost of goods, and accelerate development timelines through platform-based manufacturing approaches.

The summit will showcase practical insights from leading biopharma and biotech organizations including Regeneron, Sanofi, Ultragenyx, Legend Biotech, Cabaletta Bio, and Apertura Gene Therapy, providing attendees with actionable strategies to strengthen manufacturing performance, improve product quality, and support successful clinical and commercial outcomes.

Join a community of viral vector experts dedicated to increasing productivity, reducing manufacturing and CMC burden, and building the scalable processes needed to deliver the next generation of cell and gene therapies.

Find out more today and secure your complimentary ticket: https://ter.li/2pthcqqz

Details

  • Start: February 24, 2027
  • End: February 25, 2027

Organizer

  • Hanson Wade
  • Phone UK: +44 (0)20 3141 8700 US: +1 617 455 4188
  • Email info@hansonwade.com
  • View Organizer Website

Venue

  • The Colonnade Hotel
  • 120 Huntington Ave
    Boston, MA 02116 United States
    + Google Map